N G Industries Ltd
₹ 167
0.57%
28 Feb
- close price
About
Incorporated in 1994, N G Industries Ltd is in the business of Healthcare services[1]
Key Points
- Market Cap ₹ 56.0 Cr.
- Current Price ₹ 167
- High / Low ₹ 206 / 136
- Stock P/E 4.62
- Book Value ₹ 124
- Dividend Yield 2.10 %
- ROCE 6.50 %
- ROE 5.63 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 27.4%
Cons
- The company has delivered a poor sales growth of -0.91% over past five years.
- Tax rate seems low
- Company has a low return on equity of 6.20% over last 3 years.
- Earnings include an other income of Rs.13.1 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
14 | 14 | 15 | 17 | 17 | 17 | 18 | 18 | 12 | 18 | 19 | 17 | 16 | |
11 | 11 | 12 | 14 | 14 | 14 | 15 | 16 | 11 | 16 | 17 | 15 | 14 | |
Operating Profit | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 1 | 2 | 2 | 2 | 2 |
OPM % | 21% | 20% | 18% | 18% | 17% | 18% | 16% | 15% | 11% | 13% | 10% | 12% | 11% |
1 | 1 | 1 | -0 | -0 | -0 | -0 | -0 | 0 | 2 | 8 | 5 | 13 | |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 |
Profit before tax | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 3 | 10 | 6 | 14 |
Tax % | 27% | 28% | 27% | 37% | 36% | 34% | 35% | 28% | 25% | 21% | 14% | 14% | |
2 | 2 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 3 | 8 | 5 | 12 | |
EPS in Rs | 6.21 | 4.54 | 4.27 | 4.57 | 4.24 | 4.21 | 3.34 | 4.39 | 1.82 | 7.79 | 24.83 | 15.01 | 36.17 |
Dividend Payout % | 56% | 77% | 82% | 77% | 83% | 83% | 105% | 0% | 0% | 45% | 14% | 23% |
Compounded Sales Growth | |
---|---|
10 Years: | 2% |
5 Years: | -1% |
3 Years: | 12% |
TTM: | -5% |
Compounded Profit Growth | |
---|---|
10 Years: | 2% |
5 Years: | 5% |
3 Years: | 41% |
TTM: | 185% |
Stock Price CAGR | |
---|---|
10 Years: | 8% |
5 Years: | 27% |
3 Years: | 37% |
1 Year: | -2% |
Return on Equity | |
---|---|
10 Years: | 9% |
5 Years: | 7% |
3 Years: | 6% |
Last Year: | 6% |
Balance Sheet
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
Reserves | 11 | 11 | 11 | 11 | 9 | 8 | 8 | 6 | 12 | 21 | 25 | 33 | 38 |
5 | 2 | 1 | 1 | 2 | 1 | 1 | 3 | 0 | 1 | 1 | 1 | 1 | |
2 | 2 | 2 | 2 | 0 | 0 | 1 | 2 | 2 | 3 | 2 | 3 | 5 | |
Total Liabilities | 20 | 18 | 17 | 17 | 14 | 14 | 13 | 14 | 17 | 27 | 31 | 40 | 48 |
6 | 6 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 6 | 5 | 6 | 6 | |
CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments | 10 | 8 | 8 | 9 | 4 | 4 | 3 | 4 | 8 | 16 | 22 | 29 | 39 |
4 | 4 | 3 | 3 | 5 | 4 | 5 | 5 | 4 | 5 | 3 | 5 | 4 | |
Total Assets | 20 | 18 | 17 | 17 | 14 | 14 | 13 | 14 | 17 | 27 | 31 | 40 | 48 |
Cash Flows
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2 | 2 | 2 | 2 | 2 | 2 | 4 | 3 | 1 | -2 | 3 | -1 | |
-4 | 2 | -1 | -1 | -1 | -2 | -1 | -3 | 2 | 1 | -2 | 2 | |
2 | -4 | -2 | -1 | -1 | -2 | -2 | 0 | -3 | 0 | -1 | -1 | |
Net Cash Flow | 0 | 0 | -1 | -0 | 0 | -1 | 1 | -0 | 1 | -0 | 0 | 1 |
Ratios
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 2 | 2 | 5 | 6 | 9 | 10 | 11 | 9 | 10 | 15 | 1 | 3 |
Inventory Days | 61 | 65 | 54 | 56 | 61 | 58 | 53 | 41 | 65 | 156 | 35 | 53 |
Days Payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash Conversion Cycle | 63 | 67 | 59 | 62 | 70 | 68 | 64 | 51 | 75 | 171 | 36 | 56 |
Working Capital Days | -18 | -23 | -17 | -10 | 26 | 23 | 7 | -8 | -25 | 21 | -13 | 0 |
ROCE % | 16% | 14% | 11% | 18% | 17% | 19% | 19% | 20% | 7% | 11% | 7% | 6% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
12 Feb - Publication of Unaudited Financial Results for the quarter and nine months ended 31st December, 2024
-
Disclosure Under Regulation 30(5) Of SEBI (LODR) Regulations, 2015 - Authorization To KMPS For Determining Materiality Of An Event And Making Disclosures
11 Feb - Authorization of officials for materiality disclosures.
-
Integrated Filing (Financial)
11 Feb - Unaudited financial results for Q3 and nine months ended December 2024.
-
Board Meeting Outcome for Consideration And Approval Of Unaudited Financial Results For The Quarter And Nine Months Ended 31St December, 2024
11 Feb - Unaudited financial results for Q3 and nine months ended December 2024.
- Financial Results For Quarter And Nine Months Ended 31St December, 2024 11 Feb
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Business Overview:[1]
Company provides comprehensive healthcare services ranging from Clinics, Diagnostics, Inpatient & Outpatient Services, Pharmacy dispensing, etc.